Search for: "Pfizer Inc." Results 41 - 60 of 1,516
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Apr 2023, 5:18 am by Annsley Merelle Ward
A similar situation arose a few years in Pfizer v Roche [2019] EWHC 1520 (Pat). [read post]
24 Feb 2023, 5:40 am by Robert Kraft
Reuters reports that the US Supreme Court “turned away Pfizer Inc’s bid to revive its plan to cover out-of-pocket expenses of Medicare patients for drugs costing $225,000 a year to treat a rare heart condition,” transthyretin amyloid cardiomyopathy, “after federal officials found that the drugmaker’s arrangement could amount to illegal kickbacks. [read post]
14 Feb 2023, 12:29 pm
</span> </p> <p> <span style="display: initial;"> <br/> </span> </p> <p> <span style="display: initial;"> <span style="display: initial;"> Famous trademark infringement </span> </span> <a href=""… [read post]
1 Feb 2023, 9:05 pm by renholding
  Pfizer was a major contributor to the level of healthcare M&A, announcing a number of deals, including its $11.6 acquisition of Biohaven Pharmaceuticals, $5.4 billion acquisition of Global Blood Therapeutics and $525 million acquisition of ReViral. [read post]
3 Jan 2023, 1:47 pm by Kevin LaCroix
The directors’ and officers’ liability environment is always changing, but 2022 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
13 Dec 2022, 7:41 pm by Juvan Bonni
Duane Morris LLP Caterpillar Inc. [read post]
14 Nov 2022, 12:15 am
Food & Drug Administration, financial results, and an impending merger with a division of Pfizer Inc. [read post]
6 Oct 2022, 5:23 pm by Sabrina I. Pacifici
The study, led by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, aimed to define the clinical course and the immunologic and virologic characteristics of COVID-19 rebound in patients who have taken nirmatrelvir/ritonavir (Paxlovid), an antiviral therapeutic developed by Pfizer, Inc. [read post]
2 Sep 2022, 5:01 am by Eugene Volokh
This new article of mine will be coming out next year in the Journal of Law and Religion, and I thought I'd serialize it here; there's still plenty of time for editing, so I'd love to hear people's feedback. [read post]
31 Aug 2022, 8:51 pm by Patent Docs
Noonan -- On Friday, August 26th, Moderna Tx, Inc. and Moderna US, Inc. filed a complaint for patent infringement in Federal district court for the District of Massachusetts against Pfizer, Inc., BioNTech SE, BioNTech Manufacturing GmbH, and BioNTech US, Inc. [read post]
27 Jul 2022, 11:00 am by Zak Gowen
  UK watchdog fines Pfizer, Flynn Pharma $84 mln for overcharging NHS. [read post]
The US Court of Appeals for the Second Circuit Monday rejected an appeal from Pfizer Inc. after the Department of Health and Human Services (DHHS) said that Pfizer’s plan to cover patients’ copays for its heart failure medications violated US law. [read post]
21 Jun 2022, 9:42 am by Laura Ray
  “As part of their original EUA requests, both ModernaTX Inc. and Pfizer Inc. submitted plans to continue to monitor the safety of the vaccines as they are used under EUA,” and these plans “have been updated to include the newly authorized populations. [read post]
25 May 2022, 2:26 am by Matrix Legal Support Service
On appeal from [2020] EWCA Civ 617 The Respondent is a public body tasked with investigating companies suspected of breaching competition law and penalising those found to have done so. [read post]
23 May 2022, 1:00 am by Matrix Legal Support Service
On Wednesday 25th May, the Court will hand down judgment in Competition and Markets Authority v Flynn Pharma Ltd and Pfizer Inc [2022] USKC 14, on appeal from [2020] EWCA Civ 617. [read post]